October 2019

Per- and Polyfluoroalkyl Substances: Contaminants of Emerging Concern

October 07, 2019

Per- and polyfluoroalkyl substances (PFAS) are a group of several thousand synthetic compounds that are found in a wide range of commodities. Perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic acid (PFOS) are two of the most regularly investigated and discussed PFAS. This brief gives an overview of the public health significance of PFAS exposures, some challenges related to PFAS for state health agencies, and recent federal actions to protect communities from PFAS.Read More »

State Approaches for Promoting Family-Centered Care for Pregnant and Postpartum Women with Substance Use Disorders

October 02, 2019

The use of opioids and other substances during pregnancy has increased significantly in the past decade, and so too have complications from their use. Opioid and substance use disorders (SUD) continue to affect families beyond pregnancy; in 2017, about one in eight (8.7 million) U.S. children lived in a household where at least one parent had a SUD in the prior year. This brief discusses opportunities to engage families in SUD treatment.Read More »

Stigma Reinforces Barriers to Care for Pregnant and Postpartum Women with Substance Use Disorder

September 30, 2019

Substance use disorder (SUD) among pregnant and postpartum women is an increasingly pressing public health concern. Between 1999 and 2014, the number of women with opioid use disorder who gave birth increased 333 percent. This resource provides recommendations for addressing the stigma these women face.Read More »

See additional content »